Deanna L. Kelly

Statistics

Publications

148

Citations

7.2K

H-Index

Active since

1998

Affiliations

University of Maryland, Baltimore(Current)

National Institute on Drug Abuse

University of Maryland, College Park

Johns Hopkins University

National Institutes of Health

Deanna L. Kelly is an author at University of Maryland, Baltimore specializing in psychiatry, psychopharmacology, and schizophrenia spectrum disorders.

ORCID

Publications per year

1998–2025

148

Publications

148

Blood–brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders

Maria Fiorentino, Anna Sapone, Stefania Senger et al. · Molecular Autism · 2016 · 479 citations · Full text

Life Sciences, Immunology, Neuroscience +17

An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

José de León, Georgios Schoretsanitis, Robert L. Smith et al. · Pharmacopsychiatry · 2021 · 259 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Adjunctive Treatment With a Dopamine Partial Agonist, Aripiprazole, for Antipsychotic-Induced Hyperprolactinemia: A Placebo-Controlled Trial

Joo-Cheol Shim, Jae-Goo K Shin, Deanna L. Kelly et al. · American Journal of Psychiatry · 2007 · 214 citations

Medicine, Pharmacotherapy, Psychiatry +17

Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles

Jacqueline I. Goldstein, L. Fredrik Jarskog, Chris Hilliard et al. · Nature Communications · 2014 · 180 citations · Full text

Life Sciences, Genetics, Immunology +11

Prevalence of Celiac Disease and Gluten Sensitivity in the United States Clinical Antipsychotic Trials of Intervention Effectiveness Study Population

Nicola G. Cascella, D. Kryszak, Bushra Bhatti et al. · Schizophrenia Bulletin · 2009 · 167 citations · Full text

Medicine, Immunology, Psychiatry +17

1–5 of 148